Shapira, M Y <br/><br/>
Alefacept treatment for refractory chronic extensive GVHD.  [electronic resource] 

 -  Bone marrow transplantation  Feb 2009 
 - 339-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2008.324  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Alefacept<br/>Child, Preschool<br/>Chronic Disease<br/>Cohort Studies<br/>Female<br/>Graft vs Host Disease--drug therapy<br/>Humans<br/>Immunologic Memory--drug effects<br/>Immunosuppressive Agents--adverse effects<br/>Male<br/>Middle Aged<br/>Recombinant Fusion Proteins--adverse effects<br/>Stem Cell Transplantation--adverse effects<br/>T-Lymphocytes--drug effects<br/>Young Adult